Stock daily read

What happened with LMRI today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

LMRI in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Lumexa Imaging Holdings, Inc. operates outpatient imaging centers in the United States where patients referred by physicians receive scans and radiologists interpret the images. This center business supplies most of its revenue, with MRI and CT contributing more than half of revenue. Commercial health insurers are the largest source of payment, followed by government programs such as Medicare and Medicaid; patients and other payors supply the remainder.

Lumexa operates both its own centers and centers jointly owned with health systems. At joint-venture centers, it earns management fees and shares in profits and cash distributions according to its ownership interest. It also has a separate professional-services business whose radiologists interpret scans performed elsewhere, mainly in hospital imaging departments.

The business depends on continued physician referrals, insurer coverage and payment rates, and enough radiologists and technologists to perform and read scans. Referring physicians generally have no obligation to send patients to Lumexa. Government programs usually pay according to set fee schedules, so raising its charges does not generally increase those payments. Centers need licenses and accreditation, while state restrictions on corporate medical practice and fee splitting limit how Lumexa may structure its relationships with physicians and require it to preserve their medical judgment.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in LMRI’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

LMRI says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

Lumexa Imaging’s results hinge on physician referrals for MRI and CT scans, insurer reimbursement and the performance of its health-system joint ventures.

  • RadNet, Inc. competes with Lumexa Imaging for physician-referred patients needing MRI, CT and other scans; both operate outpatient imaging centers, including through health-system joint ventures. Watch RadNet’s imaging-center revenue rather than its software and AI sales for the closer comparison with Lumexa’s business.

Agenda

in 8 daysWed, Oct 28

  1. 2:00 PMET

    Fed Interest Rate Decision

    Lumexa’s Fed-linked rate backdrop matters because it can lift or ease SOFR, the benchmark rate on its $825 million term loan, changing interest paid and cash left for imaging operations.

in 20 daysMon, Nov 9

  1. Time to be announced

    RadNet, Inc. earningsRDNT

    RadNet’s report will show what its imaging centers earn from scans, a read on demand and reimbursement for the physician-referred patients it and Lumexa Imaging Holdings compete to serve.

in 22 daysWed, Nov 11

  1. Time to be announced
    Major

    Lumexa Imaging Holdings, Inc. earningsThis company

    Lumexa Imaging Holdings’ report will show whether its imaging centers and radiologists are turning more scans into enough revenue to cover fixed costs.